Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Liver transarterial embolizations in metastatic neuroendocrine tumors
L de Mestier, M Zappa, O Hentic, V Vilgrain… - Reviews in Endocrine …, 2017 - Springer
The management of patients with well-differentiated neuroendocrine tumors (NET) and non-
resectable liver metastases is challenging. Liver-directed transarterial embolization (TAE) …
resectable liver metastases is challenging. Liver-directed transarterial embolization (TAE) …
[HTML][HTML] Radioembolisation with 90Y microspheres for neuroendocrine liver metastases: an institutional case series, systematic review and meta-analysis
Background Neuroendocrine liver metastases are clinically challenging due to their frequent
disseminated distribution. This study aims to present a British experience with an emerging …
disseminated distribution. This study aims to present a British experience with an emerging …
Radioembolization with 90Y Resin Microspheres of Neuroendocrine Liver Metastases: International Multicenter Study on Efficacy and Toxicity
Purpose Radioembolization of liver metastases of neuroendocrine neoplasms (NEN) has
shown promising results; however, the current literature is of limited quality. A large …
shown promising results; however, the current literature is of limited quality. A large …
Comparison of Tc-99m MAA planar versus SPECT/CT imaging for lung shunt fraction evaluation prior to Y-90 radioembolization: are we overestimating lung shunt …
Purpose To compare lung shunt fraction (LSF) prior to Y-90 radioembolization calculated
using planar imaging versus SPECT/CT in patients with hepatocellular carcinoma (HCC) …
using planar imaging versus SPECT/CT in patients with hepatocellular carcinoma (HCC) …
Epidemiology, treatment and outcomes of gastroenteropancreatic neuroendocrine neoplasms
To investigate incidence, treatment patterns and outcomes of gastroenteropancreatic
neuroendocrine neoplasms (GEP-NEN) in the United States. The 2019 National Cancer …
neuroendocrine neoplasms (GEP-NEN) in the United States. The 2019 National Cancer …
[HTML][HTML] Predictive factors for resistant disease with Medical/Radiologic/Liver-directed anti-tumor treatments in patients with advanced pancreatic neuroendocrine …
Simple Summary Tumor resistance, both primary and acquired, is leading to increased
complexity in the nonsurgical treatment of patients with advanced panNENs, which would be …
complexity in the nonsurgical treatment of patients with advanced panNENs, which would be …
Systematic review of lung shunt fraction quantification comparing SPECT/CT and planar scintigraphy for yttrium 90 radioembolization planning
Purpose Yttrium 90-labeled intra-arterial liver therapy is an effective treatment for patients
with unresectable primary or metastatic liver malignancy. Optimal radioisotope dose …
with unresectable primary or metastatic liver malignancy. Optimal radioisotope dose …
Metastatic liver disease: indications for locoregional therapy and supporting data
S Shamimi-Noori, CF Gonsalves… - Seminars in …, 2017 - thieme-connect.com
Metastatic liver disease is a major cause of cancer-related morbidity and mortality. Surgical
resection is considered the only curative treatment, yet only a minority is eligible. Patients …
resection is considered the only curative treatment, yet only a minority is eligible. Patients …
Neuroendocrine tumor liver metastases treated with yttrium-90 radioembolization
Abstract Objective Yttrium-90 (Y-90) radioembolization is an emerging treatment option for
unresectable neuroendocrine liver metastases (NELM). However, the data regarding this …
unresectable neuroendocrine liver metastases (NELM). However, the data regarding this …
90Y radioembolization dosimetry using a simple semi-quantitative method in intrahepatic cholangiocarcinoma: Glass versus resin microspheres
Introduction There are two different types of 90 Y Microspheres, glass and resin, in the
market for 90 Y radioembolization (90 Y-RE). This study aimed to investigate the dose of …
market for 90 Y radioembolization (90 Y-RE). This study aimed to investigate the dose of …